The Who
- Global biopharmaceutical manufacturer
- Specialists in rare diseases
- Operating in 80 countries, including US, UK, and Japan
The Challenge
- Recent acquisition meant closer integration of technology between both businesses
- Part of transition involved the evaluation of branch/office locations
- Integration would occur on a global scale
The Solution
- Servium provided 4 on-site consultants to cover technical architecture, project management, and installation services
- Plan for global integration of offices proposed
- When each office was confirmed as staying, consultants proposed what technology would be required for each location
- Every office re-fitted with refreshed network technology
- Where possible, legacy technology repurposed to sweat assets for longer
- Solution deployed in Australian, South American, European, and Middle Eastern offices
The Benefits
- Maximised previous technology investments
- Avoided the cost of permanent staffing for an interim project
- No need to take on full-time staff thanks to outsourcing of consultants via Servium
- Integration of offices completed across multiple countries
- Successfully completed on-time and on-budget
Why Servium?
- Longstanding, trusted relationship with customer
- Access to expertise on a global scale
- Existing managed services contract secured better commercials and priority resource
- Highly flexible at every stage of project
